サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1170767

世界のインフルエンザ点鼻ワクチン市場：産業調査報告書、成長動向と競合分析 (2022年～2028年)

Global Nasal Flu Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
出版日: | 発行: QYResearch | ページ情報: 英文 86 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
世界のインフルエンザ点鼻ワクチン市場：産業調査報告書、成長動向と競合分析 (2022年～2028年)
出版日: 2022年12月13日
発行: QYResearch
ページ情報: 英文 86 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、インフルエンザ点鼻ワクチン (Nasal Flu Vaccine) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査対象範囲
  • 市場 セグメントタイプ別
    • 世界のインフルエンザ点鼻ワクチンの市場規模成長率：タイプ別 (2017 VS 2021 VS 2028)
    • Trivalent Flu Vaccine
    • Quadrivalent Flu Vaccine
  • 市場セグメント：用途別
    • 世界のインフルエンザ点鼻ワクチンの市場シェア：用途別 (2017 VS 2021 VS 2028)
    • Child
    • Adult
  • 調査目的
  • 対象期間

第2章 市場展望

  • 世界のインフルエンザ点鼻ワクチン 市場規模 (2017-2028)
    • 世界のインフルエンザ点鼻ワクチンの収益 (2017-2028)
    • 世界のインフルエンザ点鼻ワクチン 売上 (2017-2028)
  • 世界のインフルエンザ点鼻ワクチン 世界の主要地域における市場規模: 2017 VS 2021 VS 2028
    • 世界のインフルエンザ点鼻ワクチン 販売：地域別 (2017-2022)
    • 世界のインフルエンザ点鼻ワクチン 収益：地域別 (2017-2022)
  • 世界のインフルエンザ点鼻ワクチン 市場規模予測：地域別
    • 世界のインフルエンザ点鼻ワクチンの販売予測：地域別 (2023-2028)
    • 世界のインフルエンザ点鼻ワクチンの収益予測：地域別 (2023-2028)
  • 世界のトップ インフルエンザ点鼻ワクチン 地域（国） ランキング別 市場規模
  • インフルエンザ点鼻ワクチン 市場動向
    • インフルエンザ点鼻ワクチン 市場トレンド
    • インフルエンザ点鼻ワクチン 市場の促進要因
    • インフルエンザ点鼻ワクチン 市場の課題
    • インフルエンザ点鼻ワクチン 市場の抑制要因

第3章 競争状況：企業別

  • 世界のトップ インフルエンザ点鼻ワクチンの上位企業：販売別 (2017-2022)
    • 世界のインフルエンザ点鼻ワクチンの販売：企業別 (2017-2022)
    • 世界のインフルエンザ点鼻ワクチンの販売市場シェア：企業別 (2017-2022)
    • 世界の5大・10大企業 インフルエンザ点鼻ワクチン 売上2021
  • 世界のトップ 企業 インフルエンザ点鼻ワクチン 収益別
    • 世界のインフルエンザ点鼻ワクチンの収益：企業別 (2017-2022)
    • トップ インフルエンザ点鼻ワクチン 企業：収益別ランキング
    • 世界のインフルエンザ点鼻ワクチンの収益シェア：企業別 (2017-2022)
    • 世界のインフルエンザ点鼻ワクチン 市場集中度 (CR5 ・ HHI)
  • 世界のトップ 企業 企業タイプ別 (Tier 1, Tier 2 ・ Tier 3) & (売上高に基づいたインフルエンザ点鼻ワクチン (2021年時点))
  • 世界のインフルエンザ点鼻ワクチン 企業別平均販売価格(ASP)
  • 主要企業 インフルエンザ点鼻ワクチン 工場・事業所分布と供給地域
  • 主要企業の参入時期 インフルエンザ点鼻ワクチン 市場
  • 主要企業 インフルエンザ点鼻ワクチン 取扱商品
  • M&A, 拡張計画

第4章 世界のインフルエンザ点鼻ワクチン 市場規模：タイプ別

  • 世界のインフルエンザ点鼻ワクチンの過去の市場概要：タイプ別 (2017-2022)
    • 世界のインフルエンザ点鼻ワクチンの販売市場シェア：タイプ別 (2017-2022)
    • 世界のインフルエンザ点鼻ワクチンの収益市場シェア：タイプ別 (2017-2022)
    • インフルエンザ点鼻ワクチンの価格：タイプ別 (2017-2022)
  • 世界のインフルエンザ点鼻ワクチンの市場 推定および予測：タイプ別 (2023-2028)
    • 世界のインフルエンザ点鼻ワクチンの販売予測：タイプ別 (2023-2028)
    • 世界のインフルエンザ点鼻ワクチンの収益予測：タイプ別 (2023-2028)
    • インフルエンザ点鼻ワクチンの価格予測：タイプ別 (2023-2028)

第5章 世界のインフルエンザ点鼻ワクチン 市場規模：用途別

  • 世界のインフルエンザ点鼻ワクチンの過去の市場概要：用途別 (2017-2022)
    • 世界のインフルエンザ点鼻ワクチンの販売市場シェア：用途別 (2017-2022)
    • 世界のインフルエンザ点鼻ワクチンの収益市場シェア：用途別 (2017-2022)
    • インフルエンザ点鼻ワクチンの価格：用途別 (2017-2022)
  • 世界のインフルエンザ点鼻ワクチンの市場 推定および予測：用途別 (2023-2028)
    • 世界のインフルエンザ点鼻ワクチンの販売予測：用途別 (2023-2028)
    • 世界のインフルエンザ点鼻ワクチンの収益予測：用途別 (2023-2028)
    • インフルエンザ点鼻ワクチンの価格予測：用途別 (2023-2028)

第6章 北米

  • 北米のインフルエンザ点鼻ワクチン 売上内訳：企業別
    • 北米のインフルエンザ点鼻ワクチン 売上：企業別 (2017-2022)
    • 北米のインフルエンザ点鼻ワクチン 収益：企業別 (2017-2022)
  • 北米のインフルエンザ点鼻ワクチン 市場規模：タイプ別
    • 北米のインフルエンザ点鼻ワクチンの販売：タイプ別 (2017-2028)
    • 北米のインフルエンザ点鼻ワクチンの収益：タイプ別 (2017-2028)
  • 北米のインフルエンザ点鼻ワクチン 市場規模：用途別
    • 北米のインフルエンザ点鼻ワクチンの販売：用途別 (2017-2028)
    • 北米のインフルエンザ点鼻ワクチンの収益：用途別 (2017-2028)
  • 北米のインフルエンザ点鼻ワクチン 市場規模：国別
    • 北米のインフルエンザ点鼻ワクチンの販売：国別 (2017-2028)
    • 北米のインフルエンザ点鼻ワクチンの収益：国別 (2017-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州のインフルエンザ点鼻ワクチン 売上内訳：企業別
    • 欧州のインフルエンザ点鼻ワクチン 売上：企業別 (2017-2022)
    • 欧州のインフルエンザ点鼻ワクチン 収益：企業別 (2017-2022)
  • 欧州のインフルエンザ点鼻ワクチン 市場規模：タイプ別
    • 欧州のインフルエンザ点鼻ワクチンの販売：タイプ別 (2017-2028)
    • 欧州のインフルエンザ点鼻ワクチンの収益：タイプ別 (2017-2028)
  • 欧州のインフルエンザ点鼻ワクチン 市場規模：用途別
    • 欧州のインフルエンザ点鼻ワクチンの販売：用途別 (2017-2028)
    • 欧州のインフルエンザ点鼻ワクチンの収益：用途別 (2017-2028)
  • 欧州のインフルエンザ点鼻ワクチン 市場規模：国別
    • 欧州のインフルエンザ点鼻ワクチンの販売：国別 (2017-2028)
    • 欧州のインフルエンザ点鼻ワクチンの収益：国別 (2017-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 アジア太平洋

  • アジア太平洋のインフルエンザ点鼻ワクチン 売上内訳：企業別
    • アジア太平洋のインフルエンザ点鼻ワクチン 売上：企業別 (2017-2022)
    • アジア太平洋のインフルエンザ点鼻ワクチン 収益：企業別 (2017-2022)
  • アジア太平洋のインフルエンザ点鼻ワクチン 市場規模：タイプ別
    • アジア太平洋のインフルエンザ点鼻ワクチンの販売：タイプ別 (2017-2028)
    • アジア太平洋のインフルエンザ点鼻ワクチンの収益：タイプ別 (2017-2028)
  • アジア太平洋のインフルエンザ点鼻ワクチン 市場規模：用途別
    • アジア太平洋のインフルエンザ点鼻ワクチンの販売：用途別 (2017-2028)
    • アジア太平洋のインフルエンザ点鼻ワクチンの収益：用途別 (2017-2028)
  • アジア太平洋のインフルエンザ点鼻ワクチン 市場規模：地域別
    • アジア太平洋のインフルエンザ点鼻ワクチンの販売：地域別
    • アジア太平洋のインフルエンザ点鼻ワクチンの収益：地域別
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア
    • 台湾
    • インドネシア
    • タイ
    • マレーシア

第9章 ラテンアメリカ

  • ラテンアメリカのインフルエンザ点鼻ワクチン 売上内訳：企業別
    • ラテンアメリカのインフルエンザ点鼻ワクチン 売上：企業別 (2017-2022)
    • ラテンアメリカのインフルエンザ点鼻ワクチン 収益：企業別 (2017-2022)
  • ラテンアメリカのインフルエンザ点鼻ワクチン 市場規模：タイプ別
    • ラテンアメリカのインフルエンザ点鼻ワクチンの販売：タイプ別 (2017-2028)
    • ラテンアメリカのインフルエンザ点鼻ワクチンの収益：タイプ別 (2017-2028)
  • ラテンアメリカのインフルエンザ点鼻ワクチン 市場規模：用途別
    • ラテンアメリカのインフルエンザ点鼻ワクチンの販売：用途別 (2017-2028)
    • ラテンアメリカのインフルエンザ点鼻ワクチンの収益：用途別 (2017-2028)
  • ラテンアメリカのインフルエンザ点鼻ワクチン 市場規模：国別
    • ラテンアメリカのインフルエンザ点鼻ワクチンの販売：国別 (2017-2028)
    • ラテンアメリカのインフルエンザ点鼻ワクチンの収益：国別 (2017-2028)
    • メキシコ
    • ブラジル
    • アルゼンチン

第10章 中東・アフリカ

  • 中東・アフリカのインフルエンザ点鼻ワクチン 売上内訳：企業別
    • 中東・アフリカのインフルエンザ点鼻ワクチン 売上：企業別 (2017-2022)
    • 中東・アフリカのインフルエンザ点鼻ワクチン 収益：企業別 (2017-2022)
  • 中東・アフリカのインフルエンザ点鼻ワクチン 市場規模：タイプ別
    • 中東・アフリカのインフルエンザ点鼻ワクチンの販売：タイプ別 (2017-2028)
    • 中東・アフリカのインフルエンザ点鼻ワクチンの収益：タイプ別 (2017-2028)
  • 中東・アフリカのインフルエンザ点鼻ワクチン 市場規模：用途別
    • 中東・アフリカのインフルエンザ点鼻ワクチンの販売：用途別 (2017-2028)
    • 中東・アフリカのインフルエンザ点鼻ワクチンの収益：用途別 (2017-2028)
  • 中東・アフリカのインフルエンザ点鼻ワクチン 市場規模：国別
    • 中東・アフリカのインフルエンザ点鼻ワクチンの販売：国別 (2017-2028)
    • 中東・アフリカのインフルエンザ点鼻ワクチンの収益：国別 (2017-2028)
    • トルコ
    • サウジアラビア
    • UAE

第11章 企業プロファイル

  • AstraZeneca

第12章 バリューチェーンと販売チャネルの分析

  • インフルエンザ点鼻ワクチン バリューチェーンの分析
  • インフルエンザ点鼻ワクチン 主要原材料分析
    • 主要原材料分析
    • 原材料の主要サプライヤー
  • インフルエンザ点鼻ワクチン 生産形態とプロセス
  • インフルエンザ点鼻ワクチン 販売およびマーケティング
    • インフルエンザ点鼻ワクチン 販売チャネル
    • インフルエンザ点鼻ワクチン 卸業者
  • インフルエンザ点鼻ワクチン 顧客

第13章 市場調査結果と結論

第14章 付録

図表

List of Tables

  • Table 1. Global Nasal Flu Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 2. Major Manufacturers of Trivalent Flu Vaccine
  • Table 3. Major Manufacturers of Quadrivalent Flu Vaccine
  • Table 4. Global Nasal Flu Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 5. Global Nasal Flu Vaccine Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
  • Table 6. Global Nasal Flu Vaccine Sales by Region (2017-2022) & (K Units)
  • Table 7. Global Nasal Flu Vaccine Sales Market Share by Region (2017-2022)
  • Table 8. Global Nasal Flu Vaccine Revenue by Region (2017-2022) & (US$ Million)
  • Table 9. Global Nasal Flu Vaccine Revenue Market Share by Region (2017-2022)
  • Table 10. Global Nasal Flu Vaccine Sales Forecast by Region (2023-2028) & (K Units)
  • Table 11. Global Nasal Flu Vaccine Sales Market Share Forecast by Region (2023-2028)
  • Table 12. Global Nasal Flu Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
  • Table 13. Global Nasal Flu Vaccine Revenue Market Share Forecast by Region (2023-2028)
  • Table 14. Top Nasal Flu Vaccine Regions (Countries) Ranking by Market Size (US$ Million) in 2021
  • Table 15. Nasal Flu Vaccine Market Trends
  • Table 16. Nasal Flu Vaccine Market Drivers
  • Table 17. Nasal Flu Vaccine Market Challenges
  • Table 18. Nasal Flu Vaccine Market Restraints
  • Table 19. Global Nasal Flu Vaccine Sales by Manufacturers (2017-2022) & (K Units)
  • Table 20. Global Nasal Flu Vaccine Sales Share by Manufacturers (2017-2022)
  • Table 21. Global Nasal Flu Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
  • Table 22. Ranking of Global Top Nasal Flu Vaccine Manufacturers by Revenue (US$ Million) in 2021
  • Table 23. Nasal Flu Vaccine Revenue Share by Manufacturers (2017-2022)
  • Table 24. Global Nasal Flu Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nasal Flu Vaccine as of 2021)
  • Table 26. Key Manufacturers Nasal Flu Vaccine Average Selling Price (ASP) & (2017-2022) & (US$/Unit)
  • Table 27. Key Manufacturers Nasal Flu Vaccine Plants/Factories Distribution
  • Table 28. Key Manufacturers Nasal Flu Vaccine Area Served
  • Table 29. Date of Key Manufacturers Enter into Nasal Flu Vaccine Market
  • Table 30. Key Manufacturers Nasal Flu Vaccine Product Type
  • Table 31. Mergers & Acquisitions, Expansion Plans
  • Table 32. Global Nasal Flu Vaccine Sales (K Units) by Type (2017-2022)
  • Table 33. Global Nasal Flu Vaccine Sales Share by Type (2017-2022)
  • Table 34. Global Nasal Flu Vaccine Revenue (US$ Million) Market Share by Type (2017-2022)
  • Table 35. Global Nasal Flu Vaccine Price (K Units) by Type (2017-2022)
  • Table 36. Global Nasal Flu Vaccine Sales (K Units) by Type (2023-2028)
  • Table 37. Global Nasal Flu Vaccine Sales Share by Type (2023-2028)
  • Table 38. Global Nasal Flu Vaccine Revenue (US$ Million) Market Share by Type (2023-2028)
  • Table 39. Global Nasal Flu Vaccine Revenue Share by Type (2023-2028)
  • Table 40. Global Nasal Flu Vaccine Price (K Units) by Type (2023-2028)
  • Table 41. Global Nasal Flu Vaccine Sales (K Units) by Application (2017-2022)
  • Table 42. Global Nasal Flu Vaccine Sales Share by Application (2017-2022)
  • Table 43. Global Nasal Flu Vaccine Revenue (US$ Million) Market Share by Application (2017-2022)
  • Table 44. Global Nasal Flu Vaccine Price (K Units) by Application (2017-2022)
  • Table 45. Global Nasal Flu Vaccine Sales (K Units) by Application (2023-2028)
  • Table 46. Global Nasal Flu Vaccine Sales Share by Application (2023-2028)
  • Table 47. Global Nasal Flu Vaccine Revenue (US$ Million) Market Share by Application (2023-2028)
  • Table 48. Global Nasal Flu Vaccine Revenue Share by Application (2023-2028)
  • Table 49. Global Nasal Flu Vaccine Price (K Units) by Application (2023-2028)
  • Table 50. North America Nasal Flu Vaccine Sales by Company (2017-2022) & (K Units)
  • Table 51. North America Nasal Flu Vaccine Sales Market Share by Company (2017-2022)
  • Table 52. North America Nasal Flu Vaccine Revenue by Company (2017-2022) & (US$ Million)
  • Table 53. North America Nasal Flu Vaccine Revenue Market Share by Company (2017-2022)
  • Table 54. North America Nasal Flu Vaccine Sales by Type (2017-2022) & (K Units)
  • Table 55. North America Nasal Flu Vaccine Sales by Type (2023-2028) & (K Units)
  • Table 56. North America Nasal Flu Vaccine Revenue by Type (2017-2022) & (US$ Million)
  • Table 57. North America Nasal Flu Vaccine Revenue by Type (2023-2028) & (US$ Million)
  • Table 58. North America Nasal Flu Vaccine Sales by Application (2017-2022) & (K Units)
  • Table 59. North America Nasal Flu Vaccine Sales by Application (2023-2028) & (K Units)
  • Table 60. North America Nasal Flu Vaccine Revenue by Application (2017-2022) & (US$ Million)
  • Table 61. North America Nasal Flu Vaccine Revenue by Application (2023-2028) & (US$ Million)
  • Table 62. North America Nasal Flu Vaccine Sales by Country (2017-2022) & (K Units)
  • Table 63. North America Nasal Flu Vaccine Sales by Country (2023-2028) & (K Units)
  • Table 64. North America Nasal Flu Vaccine Revenue by Country (2017-2022) & (US$ Million)
  • Table 65. North America Nasal Flu Vaccine Revenue by Country (2023-2028) & (US$ Million)
  • Table 66. Europe Nasal Flu Vaccine Sales by Company (2017-2022) & (K Units)
  • Table 67. Europe Nasal Flu Vaccine Sales Market Share by Company (2017-2022)
  • Table 68. Europe Nasal Flu Vaccine Revenue by Company (2017-2022) & (US$ Million)
  • Table 69. Europe Nasal Flu Vaccine Revenue Market Share by Company (2017-2022)
  • Table 70. Europe Nasal Flu Vaccine Sales by Type (2017-2022) & (K Units)
  • Table 71. Europe Nasal Flu Vaccine Sales by Type (2023-2028) & (K Units)
  • Table 72. Europe Nasal Flu Vaccine Revenue by Type (2017-2022) & (US$ Million)
  • Table 73. Europe Nasal Flu Vaccine Revenue by Type (2023-2028) & (US$ Million)
  • Table 74. Europe Nasal Flu Vaccine Sales by Application (2017-2022) & (K Units)
  • Table 75. Europe Nasal Flu Vaccine Sales by Application (2023-2028) & (K Units)
  • Table 76. Europe Nasal Flu Vaccine Revenue by Application (2017-2022) & (US$ Million)
  • Table 77. Europe Nasal Flu Vaccine Revenue by Application (2023-2028) & (US$ Million)
  • Table 78. Europe Nasal Flu Vaccine Sales by Country (2017-2022) & (K Units)
  • Table 79. Europe Nasal Flu Vaccine Sales by Country (2023-2028) & (K Units)
  • Table 80. Europe Nasal Flu Vaccine Revenue by Country (2017-2022) & (US$ Million)
  • Table 81. Europe Nasal Flu Vaccine Revenue by Country (2023-2028) & (US$ Million)
  • Table 82. Asia Pacific Nasal Flu Vaccine Sales by Company (2017-2022) & (K Units)
  • Table 83. Asia Pacific Nasal Flu Vaccine Sales Market Share by Company (2017-2022)
  • Table 84. Asia Pacific Nasal Flu Vaccine Revenue by Company (2017-2022) & (US$ Million)
  • Table 85. Asia Pacific Nasal Flu Vaccine Revenue Market Share by Company (2017-2022)
  • Table 86. Asia Pacific Nasal Flu Vaccine Sales by Type (2017-2022) & (K Units)
  • Table 87. Asia Pacific Nasal Flu Vaccine Sales by Type (2023-2028) & (K Units)
  • Table 88. Asia Pacific Nasal Flu Vaccine Revenue by Type (2017-2022) & (US$ Million)
  • Table 89. Asia Pacific Nasal Flu Vaccine Revenue by Type (2023-2028) & (US$ Million)
  • Table 90. Asia Pacific Nasal Flu Vaccine Sales by Application (2017-2022) & (K Units)
  • Table 91. Asia Pacific Nasal Flu Vaccine Sales by Application (2023-2028) & (K Units)
  • Table 92. Asia Pacific Nasal Flu Vaccine Revenue by Application (2017-2022) & (US$ Million)
  • Table 93. Asia Pacific Nasal Flu Vaccine Revenue by Application (2023-2028) & (US$ Million)
  • Table 94. Asia Pacific Nasal Flu Vaccine Sales by Region (2017-2022) & (K Units)
  • Table 95. Asia Pacific Nasal Flu Vaccine Sales by Region (2023-2028) & (K Units)
  • Table 96. Asia Pacific Nasal Flu Vaccine Revenue by Region (2017-2022) & (US$ Million)
  • Table 97. Asia Pacific Nasal Flu Vaccine Revenue by Region (2023-2028) & (US$ Million)
  • Table 98. Latin America Nasal Flu Vaccine Sales by Company (2017-2022) & (K Units)
  • Table 99. Latin America Nasal Flu Vaccine Sales Market Share by Company (2017-2022)
  • Table 100. Latin America Nasal Flu Vaccine Revenue by Company (2017-2022) & (US$ Million)
  • Table 101. Latin America Nasal Flu Vaccine Revenue Market Share by Company (2017-2022)
  • Table 102. Latin America Nasal Flu Vaccine Sales by Type (2017-2022) & (K Units)
  • Table 103. Latin America Nasal Flu Vaccine Sales by Type (2023-2028) & (K Units)
  • Table 104. Latin America Nasal Flu Vaccine Revenue by Type (2017-2022) & (US$ Million)
  • Table 105. Latin America Nasal Flu Vaccine Revenue by Type (2023-2028) & (US$ Million)
  • Table 106. Latin America Nasal Flu Vaccine Sales by Application (2017-2022) & (K Units)
  • Table 107. Latin America Nasal Flu Vaccine Sales by Application (2023-2028) & (K Units)
  • Table 108. Latin America Nasal Flu Vaccine Revenue by Application (2017-2022) & (US$ Million)
  • Table 109. Latin America Nasal Flu Vaccine Revenue by Application (2023-2028) & (US$ Million)
  • Table 110. Latin America Nasal Flu Vaccine Sales by Country (2017-2022) & (K Units)
  • Table 111. Latin America Nasal Flu Vaccine Sales by Country (2023-2028) & (K Units)
  • Table 112. Latin America Nasal Flu Vaccine Revenue by Country (2017-2022) & (US$ Million)
  • Table 113. Latin America Nasal Flu Vaccine Revenue by Country (2023-2028) & (US$ Million)
  • Table 114. Middle East and Africa Nasal Flu Vaccine Sales by Company (2017-2022) & (K Units)
  • Table 115. Middle East and Africa Nasal Flu Vaccine Sales Market Share by Company (2017-2022)
  • Table 116. Middle East and Africa Nasal Flu Vaccine Revenue by Company (2017-2022) & (US$ Million)
  • Table 117. Middle East and Africa Nasal Flu Vaccine Revenue Market Share by Company (2017-2022)
  • Table 118. Middle East and Africa Nasal Flu Vaccine Sales by Type (2017-2022) & (K Units)
  • Table 119. Middle East and Africa Nasal Flu Vaccine Sales by Type (2023-2028) & (K Units)
  • Table 120. Middle East and Africa Nasal Flu Vaccine Revenue by Type (2017-2022) & (US$ Million)
  • Table 121. Middle East and Africa Nasal Flu Vaccine Revenue by Type (2023-2028) & (US$ Million)
  • Table 122. Middle East and Africa Nasal Flu Vaccine Sales by Application (2017-2022) & (K Units)
  • Table 123. Middle East and Africa Nasal Flu Vaccine Sales by Application (2023-2028) & (K Units)
  • Table 124. Middle East and Africa Nasal Flu Vaccine Revenue by Application (2017-2022) & (US$ Million)
  • Table 125. Middle East and Africa Nasal Flu Vaccine Revenue by Application (2023-2028) & (US$ Million)
  • Table 126. Middle East and Africa Nasal Flu Vaccine Sales by Country (2017-2022) & (K Units)
  • Table 127. Middle East and Africa Nasal Flu Vaccine Sales by Country (2023-2028) & (K Units)
  • Table 128. Middle East and Africa Nasal Flu Vaccine Revenue by Country (2017-2022) & (US$ Million)
  • Table 129. Middle East and Africa Nasal Flu Vaccine Revenue by Country (2023-2028) & (US$ Million)
  • Table 130. AstraZeneca Corporation Information
  • Table 131. AstraZeneca Description and Overview
  • Table 132. AstraZeneca Nasal Flu Vaccine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
  • Table 133. AstraZeneca Nasal Flu Vaccine Product and Services
  • Table 134. AstraZeneca Nasal Flu Vaccine SWOT Analysis
  • Table 135. AstraZeneca Recent Developments
  • Table 136. Key Raw Materials Lists
  • Table 137. Raw Materials Key Suppliers Lists
  • Table 138. Nasal Flu Vaccine Distributors List
  • Table 139. Nasal Flu Vaccine Customers List
  • Table 140. Research Programs/Design for This Report
  • Table 141. Key Data Information from Secondary Sources
  • Table 142. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Nasal Flu Vaccine Product Picture
  • Figure 2. Global Nasal Flu Vaccine Sales Market Share by Type in 2021 & 2028
  • Figure 3. Trivalent Flu Vaccine Product Picture
  • Figure 4. Quadrivalent Flu Vaccine Product Picture
  • Figure 5. Global Nasal Flu Vaccine Sales Market Share by Application in 2021 & 2028
  • Figure 6. Child Use Case
  • Figure 7. Adult Use Case
  • Figure 8. Nasal Flu Vaccine Report Years Considered
  • Figure 9. Global Nasal Flu Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 10. Global Nasal Flu Vaccine Market Size 2017-2028 (US$ Million)
  • Figure 11. Global Nasal Flu Vaccine Sales (2017-2022) & (K Units)
  • Figure 12. Global Nasal Flu Vaccine Market Size Market Share by Region: 2021 VS 2028
  • Figure 13. Global Nasal Flu Vaccine Sales Market Share by Region (2017-2022)
  • Figure 14. Global Nasal Flu Vaccine Sales Market Share by Region in 2021
  • Figure 15. Global Nasal Flu Vaccine Revenue Market Share by Region in 2017 VS 2021
  • Figure 16. Global Nasal Flu Vaccine Sales Share by Manufacturers in 2021
  • Figure 17. The 5 and 10 Largest Manufacturers in the World: Market Share by Nasal Flu Vaccine Sales in 2021
  • Figure 18. Nasal Flu Vaccine Revenue Share by Manufacturers in 2021
  • Figure 19. Nasal Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
  • Figure 20. Global Nasal Flu Vaccine Revenue Share by Type (2017-2022)
  • Figure 21. Global Nasal Flu Vaccine Revenue Growth Rate by Type in 2017 & 2021
  • Figure 22. Global Nasal Flu Vaccine Revenue Share by Application (2017-2022)
  • Figure 23. Global Nasal Flu Vaccine Revenue Growth Rate by Application in 2017 & 2021
  • Figure 24. North America Nasal Flu Vaccine Sales Market Share by Type (2017-2028)
  • Figure 25. North America Nasal Flu Vaccine Revenue Market Share by Type (2017-2028)
  • Figure 26. North America Nasal Flu Vaccine Sales Market Share by Application (2017-2028)
  • Figure 27. North America Nasal Flu Vaccine Revenue Market Share by Application (2017-2028)
  • Figure 28. North America Nasal Flu Vaccine Sales Share by Country (2017-2028)
  • Figure 29. North America Nasal Flu Vaccine Revenue Share by Country (2017-2028)
  • Figure 30. U.S. Nasal Flu Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 31. Canada Nasal Flu Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 32. Europe Nasal Flu Vaccine Sales Market Share by Type (2017-2028)
  • Figure 33. Europe Nasal Flu Vaccine Revenue Market Share by Type (2017-2028)
  • Figure 34. Europe Nasal Flu Vaccine Sales Market Share by Application (2017-2028)
  • Figure 35. Europe Nasal Flu Vaccine Revenue Market Share by Application (2017-2028)
  • Figure 36. Europe Nasal Flu Vaccine Sales Share by Country (2017-2028)
  • Figure 37. Europe Nasal Flu Vaccine Revenue Share by Country (2017-2028)
  • Figure 38. Germany Nasal Flu Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 39. France Nasal Flu Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 40. U.K. Nasal Flu Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 41. Italy Nasal Flu Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 42. Russia Nasal Flu Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 43. Asia Pacific Nasal Flu Vaccine Sales Market Share by Type (2017-2028)
  • Figure 44. Asia Pacific Nasal Flu Vaccine Revenue Market Share by Type (2017-2028)
  • Figure 45. Asia Pacific Nasal Flu Vaccine Sales Market Share by Application (2017-2028)
  • Figure 46. Asia Pacific Nasal Flu Vaccine Revenue Market Share by Application (2017-2028)
  • Figure 47. Asia Pacific Nasal Flu Vaccine Sales Share by Region (2017-2028)
  • Figure 48. Asia Pacific Nasal Flu Vaccine Revenue Share by Region (2017-2028)
  • Figure 49. China Nasal Flu Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 50. Japan Nasal Flu Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 51. South Korea Nasal Flu Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 52. India Nasal Flu Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 53. Australia Nasal Flu Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 54. China Taiwan Nasal Flu Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 55. Indonesia Nasal Flu Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 56. Thailand Nasal Flu Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 57. Malaysia Nasal Flu Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 58. Latin America Nasal Flu Vaccine Sales Market Share by Type (2017-2028)
  • Figure 59. Latin America Nasal Flu Vaccine Revenue Market Share by Type (2017-2028)
  • Figure 60. Latin America Nasal Flu Vaccine Sales Market Share by Application (2017-2028)
  • Figure 61. Latin America Nasal Flu Vaccine Revenue Market Share by Application (2017-2028)
  • Figure 62. Latin America Nasal Flu Vaccine Sales Share by Country (2017-2028)
  • Figure 63. Latin America Nasal Flu Vaccine Revenue Share by Country (2017-2028)
  • Figure 64. Mexico Nasal Flu Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 65. Brazil Nasal Flu Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 66. Argentina Nasal Flu Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 67. Middle East and Africa Nasal Flu Vaccine Sales Market Share by Type (2017-2028)
  • Figure 68. Middle East and Africa Nasal Flu Vaccine Revenue Market Share by Type (2017-2028)
  • Figure 69. Middle East and Africa Nasal Flu Vaccine Sales Market Share by Application (2017-2028)
  • Figure 70. Middle East and Africa Nasal Flu Vaccine Revenue Market Share by Application (2017-2028)
  • Figure 71. Middle East and Africa Nasal Flu Vaccine Sales Share by Country (2017-2028)
  • Figure 72. Middle East and Africa Nasal Flu Vaccine Revenue Share by Country (2017-2028)
  • Figure 73. Turkey Nasal Flu Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 74. Saudi Arabia Nasal Flu Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 75. UAE Nasal Flu Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 76. Nasal Flu Vaccine Value Chain
  • Figure 77. Nasal Flu Vaccine Production Process
  • Figure 78. Channels of Distribution
  • Figure 79. Distributors Profiles
  • Figure 80. Bottom-up and Top-down Approaches for This Report
  • Figure 81. Data Triangulation
  • Figure 82. Key Executives Interviewed
目次

This research report focuses on the Nasal Flu Vaccine Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Research Scope
  • 1.2 Market Segment by Type
    • 1.2.1 Global Nasal Flu Vaccine Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
    • 1.2.2 Trivalent Flu Vaccine
    • 1.2.3 Quadrivalent Flu Vaccine
  • 1.3 Market Segment by Application
    • 1.3.1 Global Nasal Flu Vaccine Market Share by Application (2017 VS 2021 VS 2028)
    • 1.3.2 Child
    • 1.3.3 Adult
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Market Perspective

  • 2.1 Global Nasal Flu Vaccine Market Size (2017-2028)
    • 2.1.1 Global Nasal Flu Vaccine Revenue (2017-2028)
    • 2.1.2 Global Nasal Flu Vaccine Sales (2017-2028)
  • 2.2 Global Nasal Flu Vaccine Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
    • 2.2.1 Global Nasal Flu Vaccine Sales by Regions (2017-2022)
    • 2.2.2 Global Nasal Flu Vaccine Revenue by Regions (2017-2022)
  • 2.3 Global Nasal Flu Vaccine Market Size Forecast by Region
    • 2.3.1 Global Nasal Flu Vaccine Sales Forecast by Region (2023-2028)
    • 2.3.2 Global Nasal Flu Vaccine Revenue Forecast by Region (2023-2028)
  • 2.4 Global Top Nasal Flu Vaccine Regions (Countries) Ranking by Market Size
  • 2.5 Nasal Flu Vaccine Market Dynamics
    • 2.5.1 Nasal Flu Vaccine Market Trends
    • 2.5.2 Nasal Flu Vaccine Market Drivers
    • 2.5.3 Nasal Flu Vaccine Market Challenges
    • 2.5.4 Nasal Flu Vaccine Market Restraints

3 Competitive Landscape by Manufacturers

  • 3.1 Global Top Nasal Flu Vaccine Manufacturers by Sales (2017-2022)
    • 3.1.1 Global Nasal Flu Vaccine Sales by Manufacturers (2017-2022)
    • 3.1.2 Global Nasal Flu Vaccine Sales Market Share by Manufacturers (2017-2022)
    • 3.1.3 Global 5 and 10 Largest Manufacturers by Nasal Flu Vaccine Sales in 2021
  • 3.2 Global Top Manufacturers Nasal Flu Vaccine by Revenue
    • 3.2.1 Global Nasal Flu Vaccine Revenue by Manufacturers (2017-2022)
    • 3.2.2 Top Nasal Flu Vaccine Manufacturers Covered: Ranking by Revenue
    • 3.2.3 Global Nasal Flu Vaccine Revenue Share by Manufacturers (2017-2022)
    • 3.2.4 Global Nasal Flu Vaccine Market Concentration Ratio (CR5 and HHI)
  • 3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nasal Flu Vaccine as of 2021)
  • 3.4 Global Nasal Flu Vaccine Average Selling Price (ASP) by Manufacturers
  • 3.5 Key Manufacturers Nasal Flu Vaccine Plants/Factories Distribution and Area Served
  • 3.6 Date of Key Manufacturers Enter into Nasal Flu Vaccine Market
  • 3.7 Key Manufacturers Nasal Flu Vaccine Product Offered
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Global Nasal Flu Vaccine Market Size by Type

  • 4.1 Global Nasal Flu Vaccine Historic Market Review by Type (2017-2022)
    • 4.1.1 Global Nasal Flu Vaccine Sales Market Share by Type (2017-2022)
    • 4.1.2 Global Nasal Flu Vaccine Revenue Market Share by Type (2017-2022)
    • 4.1.3 Nasal Flu Vaccine Price by Type (2017-2022)
  • 4.2 Global Nasal Flu Vaccine Market Estimates and Forecasts by Type (2023-2028)
    • 4.2.1 Global Nasal Flu Vaccine Sales Forecast by Type (2023-2028)
    • 4.2.2 Global Nasal Flu Vaccine Revenue Forecast by Type (2023-2028)
    • 4.2.3 Nasal Flu Vaccine Price Forecast by Type (2023-2028)

5 Global Nasal Flu Vaccine Market Size by Application

  • 5.1 Global Nasal Flu Vaccine Historic Market Review by Application (2017-2022)
    • 5.1.1 Global Nasal Flu Vaccine Sales Market Share by Application (2017-2022)
    • 5.1.2 Global Nasal Flu Vaccine Revenue Market Share by Application (2017-2022)
    • 5.1.3 Nasal Flu Vaccine Price by Application (2017-2022)
  • 5.2 Global Nasal Flu Vaccine Market Estimates and Forecasts by Application (2023-2028)
    • 5.2.1 Global Nasal Flu Vaccine Sales Forecast by Application (2023-2028)
    • 5.2.2 Global Nasal Flu Vaccine Revenue Forecast by Application (2023-2028)
    • 5.2.3 Nasal Flu Vaccine Price Forecast by Application (2023-2028)

6 North America

  • 6.1 North America Nasal Flu Vaccine Sales Breakdown by Company
    • 6.1.1 North America Nasal Flu Vaccine Sales by Company (2017-2022)
    • 6.1.2 North America Nasal Flu Vaccine Revenue by Company (2017-2022)
  • 6.2 North America Nasal Flu Vaccine Market Size by Type
    • 6.2.1 North America Nasal Flu Vaccine Sales by Type (2017-2028)
    • 6.2.2 North America Nasal Flu Vaccine Revenue by Type (2017-2028)
  • 6.3 North America Nasal Flu Vaccine Market Size by Application
    • 6.3.1 North America Nasal Flu Vaccine Sales by Application (2017-2028)
    • 6.3.2 North America Nasal Flu Vaccine Revenue by Application (2017-2028)
  • 6.4 North America Nasal Flu Vaccine Market Size by Country
    • 6.4.1 North America Nasal Flu Vaccine Sales by Country (2017-2028)
    • 6.4.2 North America Nasal Flu Vaccine Revenue by Country (2017-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Nasal Flu Vaccine Sales Breakdown by Company
    • 7.1.1 Europe Nasal Flu Vaccine Sales by Company (2017-2022)
    • 7.1.2 Europe Nasal Flu Vaccine Revenue by Company (2017-2022)
  • 7.2 Europe Nasal Flu Vaccine Market Size by Type
    • 7.2.1 Europe Nasal Flu Vaccine Sales by Type (2017-2028)
    • 7.2.2 Europe Nasal Flu Vaccine Revenue by Type (2017-2028)
  • 7.3 Europe Nasal Flu Vaccine Market Size by Application
    • 7.3.1 Europe Nasal Flu Vaccine Sales by Application (2017-2028)
    • 7.3.2 Europe Nasal Flu Vaccine Revenue by Application (2017-2028)
  • 7.4 Europe Nasal Flu Vaccine Market Size by Country
    • 7.4.1 Europe Nasal Flu Vaccine Sales by Country (2017-2028)
    • 7.4.2 Europe Nasal Flu Vaccine Revenue by Country (2017-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Nasal Flu Vaccine Sales Breakdown by Company
    • 8.1.1 Asia Pacific Nasal Flu Vaccine Sales by Company (2017-2022)
    • 8.1.2 Asia Pacific Nasal Flu Vaccine Revenue by Company (2017-2022)
  • 8.2 Asia Pacific Nasal Flu Vaccine Market Size by Type
    • 8.2.1 Asia Pacific Nasal Flu Vaccine Sales by Type (2017-2028)
    • 8.2.2 Asia Pacific Nasal Flu Vaccine Revenue by Type (2017-2028)
  • 8.3 Asia Pacific Nasal Flu Vaccine Market Size by Application
    • 8.3.1 Asia Pacific Nasal Flu Vaccine Sales by Application (2017-2028)
    • 8.3.2 Asia Pacific Nasal Flu Vaccine Revenue by Application (2017-2028)
  • 8.4 Asia Pacific Nasal Flu Vaccine Market Size by Region
    • 8.4.1 Asia Pacific Nasal Flu Vaccine Sales by Region
    • 8.4.2 Asia Pacific Nasal Flu Vaccine Revenue by Region
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 India
    • 8.4.7 Australia
    • 8.4.8 China Taiwan
    • 8.4.9 Indonesia
    • 8.4.10 Thailand
    • 8.4.11 Malaysia

9 Latin America

  • 9.1 Latin America Nasal Flu Vaccine Sales Breakdown by Company
    • 9.1.1 Latin America Nasal Flu Vaccine Sales by Company (2017-2022)
    • 9.1.2 Latin America Nasal Flu Vaccine Revenue by Company (2017-2022)
  • 9.2 Latin America Nasal Flu Vaccine Market Size by Type
    • 9.2.1 Latin America Nasal Flu Vaccine Sales by Type (2017-2028)
    • 9.2.2 Latin America Nasal Flu Vaccine Revenue by Type (2017-2028)
  • 9.3 Latin America Nasal Flu Vaccine Market Size by Application
    • 9.3.1 Latin America Nasal Flu Vaccine Sales by Application (2017-2028)
    • 9.3.2 Latin America Nasal Flu Vaccine Revenue by Application (2017-2028)
  • 9.4 Latin America Nasal Flu Vaccine Market Size by Country
    • 9.4.1 Latin America Nasal Flu Vaccine Sales by Country (2017-2028)
    • 9.4.2 Latin America Nasal Flu Vaccine Revenue by Country (2017-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil
    • 9.4.5 Argentina

10 Middle East and Africa

  • 10.1 Middle East and Africa Nasal Flu Vaccine Sales Breakdown by Company
    • 10.1.1 Middle East and Africa Nasal Flu Vaccine Sales by Company (2017-2022)
    • 10.1.2 Middle East and Africa Nasal Flu Vaccine Revenue by Company (2017-2022)
  • 10.2 Middle East and Africa Nasal Flu Vaccine Market Size by Type
    • 10.2.1 Middle East and Africa Nasal Flu Vaccine Sales by Type (2017-2028)
    • 10.2.2 Middle East and Africa Nasal Flu Vaccine Revenue by Type (2017-2028)
  • 10.3 Middle East and Africa Nasal Flu Vaccine Market Size by Application
    • 10.3.1 Middle East and Africa Nasal Flu Vaccine Sales by Application (2017-2028)
    • 10.3.2 Middle East and Africa Nasal Flu Vaccine Revenue by Application (2017-2028)
  • 10.4 Middle East and Africa Nasal Flu Vaccine Market Size by Country
    • 10.4.1 Middle East and Africa Nasal Flu Vaccine Sales by Country (2017-2028)
    • 10.4.2 Middle East and Africa Nasal Flu Vaccine Revenue by Country (2017-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Company Profiles

  • 11.1 AstraZeneca
    • 11.1.1 AstraZeneca Corporation Information
    • 11.1.2 AstraZeneca Overview
    • 11.1.3 AstraZeneca Nasal Flu Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
    • 11.1.4 AstraZeneca Nasal Flu Vaccine Products and Services
    • 11.1.5 AstraZeneca Nasal Flu Vaccine SWOT Analysis
    • 11.1.6 AstraZeneca Recent Developments

12 Value Chain and Sales Channels Analysis

  • 12.1 Nasal Flu Vaccine Value Chain Analysis
  • 12.2 Nasal Flu Vaccine Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Nasal Flu Vaccine Production Mode & Process
  • 12.4 Nasal Flu Vaccine Sales and Marketing
    • 12.4.1 Nasal Flu Vaccine Sales Channels
    • 12.4.2 Nasal Flu Vaccine Distributors
  • 12.5 Nasal Flu Vaccine Customers

13 Research Findings and Conclusion

14 Appendix

  • 14.1 Research Methodology
    • 14.1.1 Methodology/Research Approach
    • 14.1.2 Data Source
  • 14.2 Author Details
  • 14.3 Disclaimer